NAMS – Newamsterdam Pharma Co NV
Investors holding1
Combined shares3,357,146
Combined reported value$81.6M
NAMS chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Stanley Druckenmiller narrow view | 1.97 | Added 9.3% | 3,357,146 | $81.6M | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Stanley Druckenmiller narrow view | Added 9.3% | 3,357,146 | 0.17 |
| Q4 2025 | Stanley Druckenmiller narrow view | Added 59.6% | 3,070,146 | 0.95 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Stanley Druckenmiller narrow view | Added 9.3% | 3,357,146 | 0.17 |
| Q4 2025 | Stanley Druckenmiller narrow view | Added 59.6% | 3,070,146 | 0.95 |
Reduced: reduced or closed
No tracked investor reduced or closed this position in the last 4 quarters.
History
1 peakQ3 2026: 1 tracked investors
20242026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Stanley Druckenmiller | 3.36M | 3.07M | 3.07M | 3.07M | 1.92M | 832.2K | 800.4K | 287.5K |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).